title: Cardiovascular screening with electrocardiography and echocardiography in collegiate athletes.
abstract: BACKGROUND
  Current guidelines for preparticipation screening of competitive athletes in the US include a comprehensive history and physical examination. The objective of this study was to determine the incremental value of electrocardiography and echocardiography added to a screening program consisting of history and physical examination in college athletes.
  
  
  METHODS
  Competitive collegiate athletes at a single university underwent prospective collection of medical history, physical examination, 12-lead electrocardiography, and 2-dimensional echocardiography. Electrocardiograms (ECGs) were classified as normal, mildly abnormal, or distinctly abnormal according to previously published criteria. Eligibility for competition was determined using criteria from the 36(th) Bethesda Conference on Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities.
  
  
  RESULTS
  In 964 consecutive athletes, ECGs were classified as abnormal in 334 (35%), of which 95 (10%) were distinctly abnormal. Distinct ECG abnormalities were more common in men than women (15% vs 6%, P<.001) as well as black compared with white athletes (18% vs 8%, P<.001). Echocardiographic and electrocardiographic findings initially resulted in exclusion of 9 athletes from competition, including 1 for long QT syndrome and 1 for aortic root dilatation; 7 athletes with Wolff-Parkinson-White patterns were ultimately cleared for participation. (Four received further evaluation and treatment, and 3 were determined to not need treatment.) After multivariable adjustment, black race was a statistically significant predictor of distinctly abnormal ECGs (relative risk 1.82, 95% confidence interval, 1.22-2.73; P=.01).
  
  
  CONCLUSIONS
  Distinctly abnormal ECGs were found in 10% of athletes and were most common in black men. Noninvasive screening using both electrocardiography and echocardiography resulted in identification of 9 athletes with important cardiovascular conditions, 2 of whom were excluded from competition. These findings offer a framework for performing preparticipation screening for competitive collegiate athletes.
authors: Saint Luke's Mid America Heart and Vascular Institute, Kansas City, MO 64111, USA. amagalski@cc-pc.com
authors: Anthony
authors: A
authors: Magalski
authors: Marcia
authors: M
authors: McCoy
authors: Michael
authors: M
authors: Zabel
authors: Lawrence M
authors: LM
authors: Magee
authors: Joseph
authors: J
authors: Goeke
authors: Michael L
authors: ML
authors: Main
authors: Linda
authors: L
authors: Bunten
authors: Kimberly J
authors: KJ
authors: Reid
authors: Brian M
authors: BM
authors: Ramza